Tenon Medical Inc. (TNON)
NASDAQ (CM) NASDAQ (CM) Primary 
Tenon Medical, Inc. (TNON) Q3 2025 Earnings Call Transcript
Tenon Medical, Inc. ( TNON ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Steven Foster - CEO, President & Director Kevin Williamson - Chief Financial Officer Conference Call Participants Scott Henry - Alliance Global Partners, Research Division Thomas McGovern Presentation Operator Greetings, and welcome to the Tenon Medical Third Quarter 2025 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded.
Tenon Medical, Inc. (TNON) Q2 2025 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Kevin Williamson - Chief Financial Officer Steven M. Foster - CEO, President & Director Conference Call Participants Nicholas Sherwood - Maxim Group LLC, Research Division Scott Robert Henry - Alliance Global Partners, Research Division Operator Greetings, and welcome to the Tenon, Inc. Second Quarter 2025 Earnings Conference Call.
Tenon Medical, Inc. (TNON) Q1 2025 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Steve Foster - President & Chief Executive Officer Kevin Williamson - Chief Financial Officer Conference Call Participants Scott Henry - Alliance Global Partners Nicholas Sherwood - Maxim Group Operator Greetings. And welcome to the Tenon Medical First Quarter 2025 Financial Results and Corporate Update Conference Call.
Tenon Medical, Inc. (TNON) Q4 2024 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON ) Q4 2024 Earnings Conference Call March 20, 2025 4:30 PM ET Company Participants Steve Foster - President and CEO Kevin Williamson - Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Operator Greetings. And welcome to the Tenon Medical Fourth Quarter and Full Year 2024 Financial Results and Corporate Update Conference Call.
Tenon Medical, Inc. (TNON) Q3 2024 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Steven Foster - President & CEO Kevin Williamson - CFO Conference Call Participants Anthony Vendetti - Maxim Group Operator Greetings, and welcome to the Tenon Medical Third Quarter 2024 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded.
Tenon Medical Reports Third Quarter 2024 Financial Results
~ 3Q Revenue of $0.9 Million, Consistent with Prior Quarter; Year to Date Revenue of $2.5 Million, Growth of 18.3% Compared to Prior Year ~ ~ Published Interim Analysis from MAINSAIL™ Study; Post-Market Study Supports the Safety and Efficacy of the Catamaran SI Joint Fusion System® Including Radiographic Proof of Fusion ~ ~ Initial Clinical Procedures Completed with New Catamaran SE Platform ~ ~ Granted Issuance of Three U.S. Patents ~ ~ Received Net Proceeds of ~$9.6 Million from Equity Financing Transactions ~ LOS GATOS, CA / ACCESSWIRE / November 13, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today reported financial results for the third quarter ended September 30, 2024. Third Quarter 2024 and Subsequent Highlights Revenue of $0.9 Million in the third quarter of 2024, a 1.6% decrease over the second quarter of 2024.
Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results
LOS GATOS, CA / ACCESSWIRE / October 30, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the third quarter 2024 ended September 30, 2024 after market close on Wednesday, November 13, 2024. The Company will also hold a conference call the same day at 4:30 p.m.
Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO
Tenon Now Holds 9 Granted Patents and 26 Pending Applications for the Catamaran® SI Joint Fusion System Worldwide LOS GATOS, CA / ACCESSWIRE / September 19, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced the United States Patent and Trademark Office ("USPTO") issued three (3) Notices of Allowance for U.S. Patent Application Numbers 17,469,132 and 17/468,811, both entitled "Sacroiliac Joint Stabilization Prostheses", and 18/612,032, entitled "Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints". The U.S. patents based on the applications should thus issue within the next ninety (90) days.
Tenon Medical Announces 1:8 Reverse Split
LOS GATOS, CA / ACCESSWIRE / September 4, 2024 / Tenon Medical, Inc. ("Tenon" or the "Company") (NASDAQ:TNON), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced, a 1:8 reverse stock split of the Company's issued and outstanding common stock. The reverse stock split will become effective at 12:01, Eastern Time, on September 6, 2024, prior to the commencement of trading on the Nasdaq Capital Market.
Tenon Medical Appoints Medical Device Veteran, Kevin Williamson, Chief Financial Officer
LOS GATOS, CA / ACCESSWIRE / August 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has appointed Kevin Williamson as Chief Financial Officer. Mr. Williamson's appointment succeeds the previously disclosed retirement of Steve Van Dick from the role of Chief Financial Officer.
Tenon Medical, Inc. (TNON) Q2 2024 Earnings Call Transcript
Tenon Medical, Inc. (NASDAQ:TNON ) Q2 2024 Earnings Conference Call August 13, 2024 4:30 PM ET Company Participants Steven Foster - CEO and President Steven Van Dick - CFO and EVP, Finance and Administration Conference Call Participants Bruce Jackson - The Benchmark Company Anthony Vendetti - Maxim Group Operator Greetings and welcome to the Tenon Medical's Second Quarter 2024 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded.
Tenon Medical Reports Second Quarter 2024 Financial Results
~ Second Quarter 2024 Revenue Increased 21% Year-Over-Year ~ ~ Surgical Procedures Increased 7% Year-Over-Year in the Second Quarter 2024 ~ ~ Gross Profit Margin of 52% Marks One Year of Generating Positive Gross Profit ~ ~ Publication of Post-Market Study Interim Analysis Now Imminent ~ LOS GATOS, CA / ACCESSWIRE / August 13, 2024 / Tenon Medical, Inc. (NASDAQ:TNON)(NASDAQ:TNONW) ("Tenon Medical" or the "Company" or "Tenon"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today reported financial results for the second quarter ended June 30, 2024. Second Quarter 2024 and Subsequent Highlights Revenue of $901,000 in the second quarter of 2024, a 21% increase over the prior year quarter and a 25% increase over the first quarter of 2024.
